Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?
- PMID: 30665396
- PMCID: PMC6341697
- DOI: 10.1186/s12913-018-3864-5
Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?
Abstract
Background: Health care reform is changing preventive services delivery. This study explored trajectories in colorectal cancer (CRC) testing over a 5-year period that included implementation of 16 Medicaid Accountable Care Organizations (ACOs, 2012) and Medicaid expansion (2014) - two provisions of the Affordable Care Act (ACA) - within the state of Oregon, USA.
Methods: Retrospective analysis of Oregon's Medicaid claims for enrollee's eligible for CRC screening (50-64 years) spanning January 2010 through December 2014. Our analysis was conducted and refined April 2016 through June 2018. The analysis assessed the annual probability of patients receiving CRC testing and the modality used (e.g., colonoscopy, fecal testing) relative to a baseline year (2010). We hypothesized that CRC testing would increase following Medicaid ACO formation - called Coordinated Care Organizations (CCOs).
Results: A total of 132,424 unique Medicaid enrollees (representing 255,192 person-years) met inclusion criteria over the 5-year study. Controlling for demographic and regional factors, the predicted probability of CRC testing was significantly higher in 2014 (+ 1.4 percentage points, p < 0.001) compared to the 2010 baseline but not in 2012 or 2013. Increased fecal testing using Fecal Occult Blood Tests (FOBT) or Fecal Immunochemical Tests (FIT) played a prominent role in 2014. The uptick in statewide fecal testing appears driven primarily by a subset of CCOs.
Conclusions: Observed CRC testing did not immediately increase following the transition to CCOs in 2012. However increased testing in 2014, may reflect a delay in implementation of interventions to increase CRC screening and/or a strong desire by newly insured Medicaid CCO members to receive preventive care.
Keywords: Accountable care organizations; Colorectal cancer; Disparities; Medicaid.
Conflict of interest statement
Ethics approval and consent to participate
The study was approved by the Oregon Health & Science University Institutional Review Board with a waiver of informed consent (IRB #8865).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees.BMC Cancer. 2022 Jan 25;22(1):106. doi: 10.1186/s12885-021-09106-7. BMC Cancer. 2022. PMID: 35078444 Free PMC article.
-
Geographic and population-level disparities in colorectal cancer testing: A multilevel analysis of Medicaid and commercial claims data.Prev Med. 2017 Aug;101:44-52. doi: 10.1016/j.ypmed.2017.05.001. Epub 2017 May 13. Prev Med. 2017. PMID: 28506715 Free PMC article.
-
Colorectal cancer screening in newly insured Medicaid members: a review of concurrent federal and state policies.BMC Health Serv Res. 2019 May 9;19(1):298. doi: 10.1186/s12913-019-4113-2. BMC Health Serv Res. 2019. PMID: 31072316 Free PMC article.
-
A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?BMC Cancer. 2018 Jan 6;18(1):40. doi: 10.1186/s12885-017-3813-4. BMC Cancer. 2018. PMID: 29304835 Free PMC article. Review.
-
The Patient Protection and Affordable Care Act: the impact on urologic cancer care.Urol Oncol. 2013 Oct;31(7):980-4. doi: 10.1016/j.urolonc.2012.01.007. Epub 2012 Jul 21. Urol Oncol. 2013. PMID: 22819697 Free PMC article. Review.
Cited by
-
Integrated health and care systems in England: can they help prevent disease?Integr Healthc J. 2020 Feb 26;2(1):e000013. doi: 10.1136/ihj-2019-000013. eCollection 2020. Integr Healthc J. 2020. PMID: 37441304 Free PMC article.
-
Enrollee characteristics and receipt of colorectal cancer testing in Pennsylvania after adoption of the Affordable Care Act Medicaid expansion.Cancer Med. 2023 Jul;12(14):15455-15467. doi: 10.1002/cam4.6168. Epub 2023 Jun 17. Cancer Med. 2023. PMID: 37329270 Free PMC article.
-
Improving colorectal cancer screening in rural primary care: Preliminary effectiveness and implementation of a collaborative mailed fecal immunochemical test pilot.J Rural Health. 2023 Jan;39(1):279-290. doi: 10.1111/jrh.12685. Epub 2022 Jun 15. J Rural Health. 2023. PMID: 35703582 Free PMC article.
-
Effects of the Colorectal Cancer Control Program.Health Econ. 2021 Nov;30(11):2667-2685. doi: 10.1002/hec.4397. Epub 2021 Aug 2. Health Econ. 2021. PMID: 34342362 Free PMC article.
-
Predictors of Colorectal Cancer Screening Modality Among Newly Age-Eligible Medicaid Enrollees.Am J Prev Med. 2021 Jan;60(1):72-79. doi: 10.1016/j.amepre.2020.08.003. Epub 2020 Nov 19. Am J Prev Med. 2021. PMID: 33223363 Free PMC article.
References
-
- American Cancer Society. Cancer Statistics Center. 2018; https://cancerstatisticscenter.cancer.org/#!/. Accessed 7 Jan 2019.
-
- American Cancer Society. Colorectal Cancer Facts & Figures 2014-2016. Atlanta: American Cancer Society. 2014.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
